Rifamycin Antibiotic
Pregnancy: Caution — used in pregnancy for TB (benefit outweighs risk); neonatal vitamin K at birth (inhibits vitamin K-dependent clotting factors)
Rifampicin
Brand names: Rimactane, Rifadin
Adult dose
Dose: TB (standard): 600 mg OD or 10 mg/kg OD (max 600 mg/day) as part of RHZE regimen. Meningococcal prophylaxis: 600 mg BD × 2 days. Staphylococcal biofilm: 300–600 mg BD in combination.
Route: Oral (or IV for serious infections)
Frequency: OD (TB) or BD (prophylaxis/biofilm)
Max: 600 mg/day (standard); higher in some specialist protocols
Powerful CYP inducer — massive drug interactions. Always used in combination (monotherapy causes rapid resistance). Turns body fluids orange-red — warn patients. NEVER use as monotherapy.
Paediatric dose
Dose: 10 mg/kg
Route: Oral
Frequency: OD
Max: 600 mg/day
Concentration: 20 mg/ml
BNF for Children: TB treatment 10–20 mg/kg OD (max 600 mg) — calculator uses 10 mg/kg (conservative standard). Meningococcal prophylaxis: 10 mg/kg BD × 2 days (neonates: 5 mg/kg BD). Source: BNF for Children 2024; NICE NG33 TB; British Thoracic Society TB Guidelines
Dose adjustments
Renal
No dose adjustment required
Hepatic
Reduce dose in severe hepatic impairment — hepatically metabolised; also hepatotoxic
Paediatric weight-based calculator
BNF for Children: TB treatment 10–20 mg/kg OD (max 600 mg) — calculator uses 10 mg/kg (conservative standard). Meningococcal prophylaxis: 10 mg/kg BD × 2 days (neonates: 5 mg/kg BD). Source: BNF for Children 2024; NICE NG33 TB; British Thoracic Society TB Guidelines
Clinical pearls
- Most potent CYP3A4, CYP2C9, P-gp inducer in clinical use — affects almost every co-prescribed drug
- OCP: warn patients rifampicin makes the pill ineffective — use barrier contraception AND for 4 weeks after stopping
- Warfarin: dose may need to be DOUBLED when starting rifampicin; carefully retitrate when stopping
- Never use as monotherapy — rapid selection of resistant mutants within days
Contraindications
- Active hepatic disease
- Porphyria
- Concurrent saquinavir/ritonavir (HIV protease inhibitors)
Side effects
- Orange-red discolouration of urine, saliva, tears, sputum (harmless — warn patient; stains contact lenses)
- Hepatotoxicity (check LFTs)
- Influenza-like syndrome (intermittent regimens)
- Thrombocytopenia
- Interstitial nephritis (rare)
- Immunological reactions (especially intermittent high-dose use)
Interactions
- CYP inducers — multiple critical interactions: reduces levels of warfarin (double dose may be needed), OCP (use barrier contraception), ciclosporin/tacrolimus, antiretrovirals (most), statins, DOACs, phenytoin, corticosteroids, methadone, clarithromycin
- Massive drug interaction list — always check BNF appendix before co-prescribing
Monitoring
- LFTs (baseline, 2 weeks, then monthly during TB treatment)
- Drug levels for co-medications (warfarin INR, ciclosporin levels, etc.)
- Orange discolouration (reassure patient)
- FBC (thrombocytopenia)
Reference: BNFc; BNF; NICE NG33 TB; British Thoracic Society TB Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
Pathways